Target intelligence / Profile preview

Fibroblast growth factor 23–Fibroblast growth factor receptor 1 complex (FGF23–FGFR1 complex)

Target
FGF23–FGFR1 complex
Molecular classification
Receptor complex, Tyrosine kinase receptor, Growth factor signaling complex
01

Overview

The Fibroblast growth factor 23–Fibroblast growth factor receptor 1 (FGF23–FGFR1) complex is a ternary signaling assembly essential for maintaining systemic phosphate homeostasis and vitamin D metabolism (UniProt Q9GZV9, P11362). The complex is formed when the bone-derived hormone FGF23 binds to the FGFR1c isoform in the presence of the transmembrane protein alpha-Klotho, which acts as an essential co-receptor to increase the affinity of FGF23 for the receptor (PMID: 17086192). Once assembled, the complex activates the MAPK/ERK signaling pathway in the renal proximal tubules, leading to the downregulation of sodium-phosphate cotransporters and the suppression of active vitamin D synthesis (PMID: 29343898). Pathological overproduction of FGF23 leads to excessive signaling through this complex, resulting in phosphate wasting diseases such as X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia (TIO) (NIH/GARD). Conversely, deficient signaling or FGF23 resistance can lead to hyperphosphatemic familial tumoral calcinosis (PubMed: 16415873). Therapeutic targeting of this complex is clinically validated by Burosumab, a monoclonal antibody that binds to FGF23 and prevents its interaction with the FGFR1-Klotho complex, thereby restoring normal phosphate levels (FDA Label: Crysvita). Additionally, pan-FGFR inhibitors used in oncology, such as Erdafitinib, can inadvertently disrupt this complex, leading to hyperphosphatemia as a common side effect (PubChem CID: 67165467). Understanding the structural and functional nuances of this complex is vital for developing treatments for mineral bone disorders and managing the toxicities of FGFR-targeted cancer therapies.

Other names
FGF23-FGFR1c-Klotho complexFGF23-FGFR1 signaling complexFGF23-FGFR-Klotho ternary complex
02

Mechanism of action

Neutralization of the FGF23 ligand to prevent assembly of the signaling complex or ATP-competitive inhibition of the FGFR1 tyrosine kinase domain to block downstream signal transduction.

03

Biological functions

Phosphate homeostasisVitamin D metabolismBone mineralizationRenal phosphate reabsorptionParathyroid hormone regulation
04

Disease associations

X-linked hypophosphatemiaTumor-induced osteomalaciaChronic kidney disease-mineral and bone disorder (CKD-MBD)Autosomal dominant hypophosphatemic ricketsHyperphosphatemic familial tumoral calcinosis
05

Safety considerations

HyperphosphatemiaEctopic calcificationNephrocalcinosisHypervitaminosis DSecondary hyperparathyroidism
06

Interacting drugs

Burosumab

4 more in the full profile.

07

Biomarkers

Serum phosphorus1,25-dihydroxyvitamin DIntact FGF23 (iFGF23)Tubular reabsorption of phosphate (TRP)Fractional excretion of phosphate (FePi)

Beyond the preview

Go deeper on Fibroblast growth factor 23–Fibroblast growth factor receptor 1 complex (FGF23–FGFR1 complex).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fibroblast growth factor 23–Fibroblast growth factor receptor 1 complex (FGF23–FGFR1 complex).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call